Researchers Discover Early Step In Stroke's Deadly Path

September 29, 1998



Finding Could Lead To New Drug Targets Against Stroke, Other Diseases


BOSTON--September 25, 1998--Researchers at Harvard Medical School have discovered an early step in the progression of stroke, a finding that could provide a new target for antistroke therapies. Stroke afflicts an estimated half million Americans each year. The study is published in the September 29 Proceedings of the National Academy of Sciences.

Scientists believe that while some brain cells are killed almost immediately in stroke by the blocking or bursting of blood vessels, others may die through exposure to compounds released by the dying neurons. Among these is glutamate, a substance that excites target neurons. One way to limit the second wave of destruction would be to stop glutamate from killing the cell. Yet the identity of the specific intracellular routes by which glutamate works its deadly, or 'excitotoxic,' effects has eluded researchers.

Beverly Murray, a research fellow in neurology at Harvard Medical School and the paper's lead author, Ed Furshpan, a professor of neurobiology at Harvard Medical School, and their colleagues have discovered that a member of the MAP kinase family known as ERK, famous for its role in such life-promoting activities as cell growth and division, may act as a kind of molecular gatekeeper, activating one or more excitotoxic pathways. Few would have suspected such a connection. "People thought the influx of glutamate activates calcium which, in turn, activates kinases. But the pathway was very fuzzy," says Furshpan.

The unexpected finding was made by mixing cultured brain cells with an ERK-blocking drug and then inducing seizures in the cells. Like stroke, seizures are believed to cause cell death through the release of excess glutamate. The researchers found the ERK-blocking drug, called PD 098059, protected cells from the deadly effects of glutamate.

"The exciting thing about this is not only that it deciphers an initial stage in the pathway of stroke, but also suggests that a pathway thought to be involved in cell proliferation may lead to damage early on in ischemia," says Alessandro Alessandrini, assistant biologist at Massachusetts General Hospital and co-author on the PNAS paper.

Intriguingly, Alessandrini and his colleagues have injected the ERK-blocking drug into seven mice, prior to blocking their cerebral blood vessels. On average, the region of cell death caused by the ensuing stroke was reduced 55 percent compared to mice who did not receive the drug.

In the experiments, PD 098059 was administered before or at the very beginning of the stroke or seizure. "So it might not be a good inhibitor once stroke is in progress," says Alessandrini. But the findings do suggest other ways to stop stroke once it has begun. For example, drugs designed to bind activated forms of ERK might prevent them from delivering their death-dealing signals. "You could also imagine designing a drug that could dephosphorylate, or deactivate, the MAP kinase," says Murray.

The recent findings join two prime scientific topics--stroke and the MAP kinases--that previously displayed only a hint of connection. Gerbils suffering from global ischemia--the blockage of blood that often leads to stroke--had been found to display high levels of MAP kinase. Intrigued by this finding, Allessandrini began his experiments in mice.

Murray and Furshpan had been using cultured cells from the hippocampus, a region of the brain prone to stroke and seizure, to study glutamate's toxic effects. They were looking for a way to block those effects when Alessandrini approached them with the idea for a collaboration.

Normally, when neurons undergo seizure for 30 minutes--with the accompanying release of glutamate--30 to 50 percent of hippocampal cells died or exhibited damage within 24 hours. Cells mixed with PD 098059 before and during seizure exhibited almost no damage. "We were surprised. It was a very dramatic effect." says Furshpan.

"What is especially exciting is that this basic excitotoxic mechanism may be important for many types of neurodegenerative disease," says Murray.
-end-


Harvard Medical School

Related Stroke Articles from Brightsurf:

Stroke alarm clock may streamline and accelerate time-sensitive acute stroke care
An interactive, digital alarm clock may speed emergency stroke care, starting at hospital arrival and through each step of the time-sensitive treatment process.

Stroke patients with COVID-19 have increased inflammation, stroke severity and death
Stroke patients who also have COVID-19 showed increased systemic inflammation, a more serious stroke severity and a much higher rate of death, compared to stroke patients who did not have COVID-19, according a retrospective, observational, cross-sectional study of 60 ischemic stroke patients admitted to UAB Hospital between late March and early May 2020.

'Time is vision' after a stroke
University of Rochester researchers studied stroke patients who experienced vision loss and found that the patients retained some visual abilities immediately after the stroke but these abilities diminished gradually and eventually disappeared permanently after approximately six months.

More stroke awareness, better eating habits may help reduce stroke risk for young adult African-Americans
Young African-Americans are experiencing higher rates of stroke because of health conditions such as high blood pressure, diabetes and obesity, yet their perception of their stroke risk is low.

How to help patients recover after a stroke
The existing approach to brain stimulation for rehabilitation after a stroke does not take into account the diversity of lesions and the individual characteristics of patients' brains.

Kids with headache after stroke might be at risk for another stroke
A new study has found a high incidence of headaches in pediatric stroke survivors and identified a possible association between post-stroke headache and stroke recurrence.

High stroke impact in low- and middle-income countries examined at 11th World Stroke Congress
Less wealthy countries struggle to meet greater need with far fewer resources.

Marijuana use might lead to higher risk of stroke, World Stroke Congress to be told
A five-year study of hospital statistics from the United States shows that the incidence of stroke has risen steadily among marijuana users even though the overall rate of stroke remained constant over the same period.

We need to talk about sexuality after stroke
Stroke survivors and their partners are not adequately supported to deal with changes to their relationships, self-identity, gender roles and intimacy following stroke, according to new research from the University of Sydney.

Standardized stroke protocol can ensure ELVO stroke patients are treated within 60 minutes
A new study shows that developing a standardized stroke protocol of having neurointerventional teams meet suspected emergent large vessel occlusion (ELVO) stroke patients upon their arrival at the hospital achieves a median door-to-recanalization time of less than 60 minutes.

Read More: Stroke News and Stroke Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.